Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 11624 | 966 | 34.2 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
| 1157 | 2 | FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1 | 9477 |
| 11624 | 1 | JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY//5 4 CHLOROBENZYL 2 4 DIMETHYLBENZAMIL | 966 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | JOHN COOK RENAL UNIT | address | 42143 | 0% | 67% | 2 |
| 2 | PLATELET HYPERSENSITIVITY | authKW | 42143 | 0% | 67% | 2 |
| 3 | 5 4 CHLOROBENZYL 2 4 DIMETHYLBENZAMIL | authKW | 31609 | 0% | 100% | 1 |
| 4 | A RISK FACTOR | authKW | 31609 | 0% | 100% | 1 |
| 5 | ABT ONKOL HAMATOL KLIN IMMUNOL RHEUMATOL PULMNO | address | 31609 | 0% | 100% | 1 |
| 6 | ACUTE FLUCTUATION | authKW | 31609 | 0% | 100% | 1 |
| 7 | ADHERENCE TO DIETARY GUIDELINES | authKW | 31609 | 0% | 100% | 1 |
| 8 | AND LYMPHOCYTES | authKW | 31609 | 0% | 100% | 1 |
| 9 | ATAKALP HEART HOSP | address | 31609 | 0% | 100% | 1 |
| 10 | ATHEROTHROMBOSE | authKW | 31609 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 7804 | 35% | 0% | 337 |
| 2 | Hematology | 4314 | 21% | 0% | 201 |
| 3 | Peripheral Vascular Diseases | 2791 | 16% | 0% | 157 |
| 4 | Medicine, Research & Experimental | 475 | 9% | 0% | 90 |
| 5 | Medicine, General & Internal | 390 | 11% | 0% | 104 |
| 6 | Nutrition & Dietetics | 163 | 4% | 0% | 39 |
| 7 | Medical Laboratory Technology | 91 | 2% | 0% | 18 |
| 8 | Cell Biology | 58 | 6% | 0% | 59 |
| 9 | Pharmacology & Pharmacy | 58 | 7% | 0% | 70 |
| 10 | Biochemistry & Molecular Biology | 39 | 10% | 0% | 99 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOHN COOK RENAL UNIT | 42143 | 0% | 67% | 2 |
| 2 | ABT ONKOL HAMATOL KLIN IMMUNOL RHEUMATOL PULMNO | 31609 | 0% | 100% | 1 |
| 3 | ATAKALP HEART HOSP | 31609 | 0% | 100% | 1 |
| 4 | AZIENDA OSPED PADOVA INTERNAL MED | 31609 | 0% | 100% | 1 |
| 5 | AZIENDA OSPED PADOVA METAB DIS | 31609 | 0% | 100% | 1 |
| 6 | CHAIR GEN PATHOL PATHOPHYSIOL | 31609 | 0% | 100% | 1 |
| 7 | CLIN CHEM CLIN MICROSCOPY | 31609 | 0% | 100% | 1 |
| 8 | CLIN CHILDREN DIS 2 | 31609 | 0% | 100% | 1 |
| 9 | ESTAB TRANSFUS SANGUINE | 31609 | 0% | 100% | 1 |
| 10 | GRP IMMUNIT MUQUEUSES AGENTS PATHOGENES EA 3064 | 31609 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | THROMBOSIS RESEARCH | 15969 | 7% | 1% | 72 |
| 2 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 14411 | 2% | 2% | 20 |
| 3 | HAEMOSTASIS | 12344 | 2% | 2% | 22 |
| 4 | ACTA DIABETOLOGICA LATINA | 10369 | 1% | 3% | 12 |
| 5 | DIABETES | 9753 | 6% | 1% | 61 |
| 6 | DIABETOLOGIA | 7331 | 5% | 1% | 44 |
| 7 | PLATELETS | 5996 | 2% | 1% | 18 |
| 8 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 5805 | 2% | 1% | 24 |
| 9 | DIABETES & METABOLISM | 5351 | 2% | 1% | 22 |
| 10 | METABOLIC PEDIATRIC AND SYSTEMIC OPHTHALMOLOGY | 4816 | 0% | 5% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | OSTERMANN, H , VANDELOO, J , (1986) FACTORS OF THE HEMOSTATIC SYSTEM IN DIABETIC-PATIENTS - A SURVEY OF CONTROLLED-STUDIES.HAEMOSTASIS. VOL. 16. ISSUE 6. P. 386-416 | 79 | 84% | 180 |
| 2 | HENDRA, T , BETTERIDGE, DJ , (1989) PLATELET-FUNCTION, PLATELET PROSTANOIDS AND VASCULAR PROSTACYCLIN IN DIABETES-MELLITUS.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 35. ISSUE 4. P. 197-212 | 71 | 65% | 47 |
| 3 | ILERI, NS , BUYUKASIK, Y , KARAAHMETOGLU, S , OZATLI, D , SAYINALP, N , OZCEBE, OI , KIRAZLI, S , MUFTUOGLU, O , DUNDAR, SV , (1999) EVALUATION OF THE HAEMOSTATIC SYSTEM DURING KETOACIDOTIC DETERIORATION OF DIABETES MELLITUS.HAEMOSTASIS. VOL. 29. ISSUE 6. P. 318-325 | 25 | 74% | 11 |
| 4 | VINIK, AI , ERBAS, T , PARK, TS , NOLAN, R , PITTENGER, GL , (2001) PLATELET DYSFUNCTION IN TYPE 2 DIABETES.DIABETES CARE. VOL. 24. ISSUE 8. P. 1476 -1485 | 34 | 38% | 237 |
| 5 | WATALA, C , (2005) BLOOD PLATELET REACTIVITY AND ITS PHARMACOLOGICAL MODULATION IN (PEOPLE WITH) DIABETES MELLITUS.CURRENT PHARMACEUTICAL DESIGN. VOL. 11. ISSUE 18. P. 2331-2365 | 64 | 22% | 48 |
| 6 | COLWELL, JA , (1988) PLATELETS, ENDOTHELIUM AND DIABETIC VASCULAR-DISEASE.DIABETES & METABOLISM. VOL. 14. ISSUE 4BIS. P. 512-518 | 30 | 94% | 7 |
| 7 | HODGSON, WC , SIKORSKI, BW , KING, RG , (1992) CARDIOVASCULAR SENSITIVITY CHANGES TO EICOSANOIDS IN RATS WITH EXPERIMENTALLY INDUCED DIABETES-MELLITUS.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 19. ISSUE 1. P. 9-15 | 29 | 74% | 3 |
| 8 | ELKHAWAND, C , JAMART, J , DONCKIER, J , CHATELAIN, B , LAVENNE, E , MORIAU, M , BUYSSCHAERT, M , (1993) HEMOSTASIS VARIABLES IN TYPE-I DIABETIC-PATIENTS WITHOUT DEMONSTRABLE VASCULAR COMPLICATIONS.DIABETES CARE. VOL. 16. ISSUE 8. P. 1137-1145 | 22 | 88% | 31 |
| 9 | ALTUNBAS, H , KARAYALCIN, U , UNDAR, L , (1998) GLYCEMIC CONTROL AND COAGULATION INHIBITORS IN DIABETIC PATIENTS.HAEMOSTASIS. VOL. 28. ISSUE 6. P. 307 -312 | 24 | 69% | 3 |
| 10 | CERIELLO, A , (1993) COAGULATION ACTIVATION IN DIABETES-MELLITUS - THE ROLE OF HYPERGLYCEMIA AND THERAPEUTIC PROSPECTS.DIABETOLOGIA. VOL. 36. ISSUE 11. P. 1119-1125 | 35 | 44% | 190 |
Classes with closest relation at Level 1 |